Open Innovation Publications & Expert Interviews Archives - Biowebspin | Biowebspin
Logo Biowebspin
#1 source of information and interviews about academia-industry partneringFollow the latest expert interviews and publications about academia-industry partnering,
technology transfer and licensing in Life Sciences

Open Innovation Publications & Expert Interviews

Event Listing: 18th Annual Drug Discovery Summit, 12-13 June 2017, Berlin

  Oxford Global’s - 18th Annual Drug Discovery Leaders’ Summit 12-13 June 2017, Hotel Palace in Berlin, Germany. Oxford Global present the 18th Annual Drug Discovery Leaders’ Summit that brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective e... »

Biotechnology firms – improvement in innovation speed

Biotechnology firms – improvement in innovation speed

  Biowebspin, April 20th, 2017 Biotechnology firms - improvement in innovation speed by Hadi Farid, Fatemeh Hakimian, Mohd Nazari Ismail, Pradeep Kumar Nair, in International Journal of Business Innovation and Research , 2017 According to the competitive and rapidly changing world of biotechnology, innovation speed is considered to be one of the fundamental organisational issues facing managers. D... »

Open innovation and company culture: Internal openness makes the difference

Open innovation and company culture: Internal openness makes the difference

  Biowebspin, April 12th, 2017 Open innovation and company culture: Internal openness makes the difference by Jan Kratzer, Dirk Meissnerb, Vitaly Roud, in Technological Forecasting and Social Change, 2017 There is a common agreement that innovation is driven by the people that form the heart of any company's innovation activity. Still, people perform innovation in a special institutional environme... »

Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics

Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics

  Biowebspin, April 12th, 2017 Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics by Jill M. Pulley, Jana K. Shirey-Rice, Robert R. Lavieri, Rebecca N. Jerome, Nicole M. Zaleski, David M. Aronoff, Lisa Bastarache, Xinnan Niu, Kenneth J. Holroyd, Dan M. Roden, Eric P. Skaar, Colleen M. Niswender, Lawrence J. Marnett, Craig W. Lindsley, Leeland B. Ekstrom, Alan... »

The venture capital in the biotechnology industry

The venture capital in the biotechnology industry

  Biowebspin, October 6th, 2016 The venture capital in the biotechnology industry by Grislain, Jacques-Henry, in DSpace, 2016 The Biotechnology investment sector has been booming over the last ten years delivering substantial financial returns for public and private investors and most VC firms have been raising and deploying a lot of capital into fast-growing Biotechnology companies. However, it m... »

Open Data for Research and Strategic Monitoring in the Pharmaceutical and Biotech Industry

Open Data for Research and Strategic Monitoring in the Pharmaceutical and Biotech Industry

  Biowebspin, April 12th, 2017 Open Data for Research and Strategic Monitoring in the Pharmaceutical and Biotech Industry by Baldissera Giovani, in Data Science Journal, 2017 Open data is considered the new oil. As oil can be used to produce fertilisers, pesticides, lubricants, plastics and many other derivatives, so data is considered the commodity to use and re-use to create value. The number of... »

Performance differences between IPOs in new industries and IPOs in established industries

Performance differences between IPOs in new industries and IPOs in established industries

  Biowebspin, September 29th, 2016 Performance differences between IPOs in new industries and IPOs in established industries by James Ang, Carol Boyer in Emerald insight, 2016 Purpose – The purpose of this paper is to provide a unique approach to examining issues related to initial public offerings (IPOs). Design/methodology/approach – The price behavior of IPOs in new industries is analyzed relat... »

How do patents affect research investments?

How do patents affect research investments?

  Biowebspin, January 30th, 2016 How do patents affect research investments? by Heidi L. Williams, 2017 While patent systems have been widely used both historically and internationally, there is nonetheless a tremendous amount of controversy over whether patent systems – in practice – improve the alignment between private returns and social contributions. In this paper, I describe three parameters... »

Crowdsourcing for translational research: analysis of biomarker expression using cancer microarrays

Crowdsourcing for translational research: analysis of biomarker expression using cancer microarrays

  Biowebspin, December 19th, 2016 Crowdsourcing for translational research: analysis of biomarker expression using cancer microarrays by Jonathan Lawson, Rupesh J Robinson-Vyas, Janette P McQuillan, Andy Paterson, Sarah Christie, Matthew Kidza-Griffiths, Leigh-Anne McDuffus, Karwan A Moutasim, Emily C Shaw, Anne E Kiltie, William J Howat, Andrew M Hanby, Gareth J Thomas and Peter Smittenaar in Bri... »

Crowdfunding FOR MEDICAL CARE: Ethical Issues in an Emerging Health Care Funding Practice.

Crowdfunding FOR MEDICAL CARE: Ethical Issues in an Emerging Health Care Funding Practice.

  Biowebspin, December 07th, 2016 Crowdfunding FOR MEDICAL CARE: Ethical Issues in an Emerging Health Care Funding Practice. by Snyder J, in Hastings Cent Rep, 2016 Crowdfunding websites allow users to post a public appeal for funding for a range of activities, including adoption, travel, research, participation in sports, and many others. One common form of crowdfunding is for expenses related to... »

Page 1 of 23123»